Abstract
Mosquirix is a vaccine that is given to children aged 6 weeks to 17 months to help protect against malaria caused by the parasite Plasmodium falciparum.
This is a summary of the European public assessment report (EPAR) for Mosquirix. It explains how the Agency assessed the medicine to recommend its approval and its conditions of use. It is not intended to provide practical advice on how to use Mosquirix.
- SAGE background document
- Malaria
